FIELD: microbiology.
SUBSTANCE: invention relates to microbiology and biotechnology. The strain Streptococcus pneumoniae 23 3-H-3 serotype 15F, intended for the production of polysaccharide used as an antigen, was deposited in the State Collection of Pathogenic Microorganisms and Cell Cultures "GKPM-Obolensk" under the number B-9846.
EFFECT: present invention enables to broaden the range of strains with increased productivity of capsular saccharide for the production of antigen for pneumococcal vaccine.
5 cl, 1 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STREPTOCOCCUS PNEUMONIAE STRAIN SEROTYPE 19A | 2022 |
|
RU2791744C1 |
| STREPTOCOCCUS PNEUMONIAE STRAIN SEROTYPE 19F | 2022 |
|
RU2804137C1 |
| STRAINS OF Streptococcus pneumoniae (VERSIONS) AND METHOD OF PRODUCING PROTECTIVE PROTEIN FRACTION, POSSESSING INTRASPECIFIC IMMUNOGENIC ACTIVITY | 2015 |
|
RU2601158C1 |
| RECOMBINANT PLASMID DNA pSp-raPLY ENCODING THE SYNTHESIS OF RECOMBINANT ATOXIC PNEUMOLYSIN PROTEIN STREPTOCOCCUS PNEUMONIAE, STRAIN OF ESCHERICHIA coli M15/pSp-raPLY BEING A PRODUCER OF RECOMBINANT ATOXIC FORM OF PNEUMOLYSIN, AND PRODUCTION OF SAID PROTEIN FOR DEVELOPING A VACCINE PRODUCT FOR PREVENTING PNEUMOCOCCAL INFECTIONS | 2021 |
|
RU2782598C1 |
| C-POLYSACCHARIDE-FREE CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE WITH A 2,5-ANHYDROMANOSE RESIDUE AT THE REDUCING END | 2023 |
|
RU2818894C1 |
| IMMUNOBIOLOGICAL AGENT BASED ON RECOMBINANT PROTEIN FOR PREVENTING PNEUMOCOCCAL INFECTION | 2024 |
|
RU2823752C1 |
| LIVE VACCINE BASED ON ENTEROCOCCUS FAECIUM L3 PROBIOTIC STRAIN FOR PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS PNEUMONIE | 2018 |
|
RU2701733C1 |
| VACCINE FOR PNEUMOCOCCAL INFECTION CONTROL | 1995 |
|
RU2087156C1 |
| POLYVALENT COMPOSITION CONTAINING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | 2013 |
|
RU2605834C2 |
| HYBRID PROTEIN VACCINE AGAINST PNEUMONIA CAUSED BY Streptococcus pneumoniae | 2012 |
|
RU2510281C2 |
